Does DABIGATRAN ETEXILATE Cause Multiple organ dysfunction syndrome? 149 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Multiple organ dysfunction syndrome have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.4% of all adverse event reports for DABIGATRAN ETEXILATE.
149
Reports of Multiple organ dysfunction syndrome with DABIGATRAN ETEXILATE
0.4%
of all DABIGATRAN ETEXILATE reports
136
Deaths
108
Hospitalizations
How Dangerous Is Multiple organ dysfunction syndrome From DABIGATRAN ETEXILATE?
Of the 149 reports, 136 (91.3%) resulted in death, 108 (72.5%) required hospitalization, and 38 (25.5%) were considered life-threatening.
Is Multiple organ dysfunction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 149 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Multiple organ dysfunction syndrome?
TACROLIMUS (1,847)
CYCLOPHOSPHAMIDE (1,597)
MYCOPHENOLATE MOFETIL (1,566)
PREDNISONE (1,525)
DEXAMETHASONE (1,355)
METHOTREXATE (1,317)
METHYLPREDNISOLONE (1,278)
RITUXIMAB (1,188)
PREDNISOLONE (1,154)
CYCLOSPORINE (933)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Multiple organ dysfunction syndrome Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB